RU2369393C2 - Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна - Google Patents

Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна Download PDF

Info

Publication number
RU2369393C2
RU2369393C2 RU2006110550/15A RU2006110550A RU2369393C2 RU 2369393 C2 RU2369393 C2 RU 2369393C2 RU 2006110550/15 A RU2006110550/15 A RU 2006110550/15A RU 2006110550 A RU2006110550 A RU 2006110550A RU 2369393 C2 RU2369393 C2 RU 2369393C2
Authority
RU
Russia
Prior art keywords
pain
day
oxcarbazepine
neuropathic pain
sleep
Prior art date
Application number
RU2006110550/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2006110550A (ru
Inventor
Доналд МАННИНГ (US)
Доналд МАННИНГ
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0320637A external-priority patent/GB0320637D0/en
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2006110550A publication Critical patent/RU2006110550A/ru
Application granted granted Critical
Publication of RU2369393C2 publication Critical patent/RU2369393C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2006110550/15A 2003-09-03 2004-09-02 Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна RU2369393C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0320637A GB0320637D0 (en) 2003-09-03 2003-09-03 Organic compounds
GB0320637.2 2003-09-03
US53737804P 2004-01-16 2004-01-16
US60/537,378 2004-01-16

Publications (2)

Publication Number Publication Date
RU2006110550A RU2006110550A (ru) 2007-12-20
RU2369393C2 true RU2369393C2 (ru) 2009-10-10

Family

ID=34276821

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006110550/15A RU2369393C2 (ru) 2003-09-03 2004-09-02 Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна

Country Status (18)

Country Link
US (1) US20060270658A1 (enExample)
EP (1) EP1663247B1 (enExample)
JP (1) JP2007513056A (enExample)
KR (1) KR20060118426A (enExample)
AT (1) ATE446759T1 (enExample)
AU (1) AU2004268381B2 (enExample)
BR (1) BRPI0414112A (enExample)
CA (1) CA2537060A1 (enExample)
DE (1) DE602004023861D1 (enExample)
IL (1) IL173822A0 (enExample)
IS (1) IS8373A (enExample)
MA (1) MA28036A1 (enExample)
MX (1) MXPA06002392A (enExample)
NO (1) NO20061515L (enExample)
RU (1) RU2369393C2 (enExample)
SG (1) SG146631A1 (enExample)
TN (1) TNSN06072A1 (enExample)
WO (1) WO2005020968A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
MX2008013675A (es) * 2006-04-26 2009-03-06 Supernus Pharmaceuticals Inc Preparaciones de liberacion controlada de oxcarbacepina que tienen perfil de liberacion sigmoidal.
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
KR102486435B1 (ko) 2022-04-25 2023-01-10 주식회사 제이비플랜트 산업용 냉동기기의 친환경 패널의 제조 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032183A2 (en) * 1999-11-02 2001-05-10 Novartis Ag Pharmaceutical compositions comprising oxcarbazepine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
US4353887A (en) 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
CO4920215A1 (es) 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
CA2497780A1 (en) * 2002-10-17 2004-04-29 Novartis Ag Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032183A2 (en) * 1999-11-02 2001-05-10 Novartis Ag Pharmaceutical compositions comprising oxcarbazepine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Реферат базы данных PubMed: BACKONJA M.M. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002 Sep 10; 59(5 Suppl 2): S14-7 [on line] PMID: 12221151 [найдено 01.08.2008]. МИХАЙЛОВ И.Б. Настольная книга врача по клинической фармакологии. СПб.: Фолиант, 2001 с.461-466, с.453. Реферат базы данных PubMed: SCHMADER K.E. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin. J. Pain.2002 Nov-Dec; 18(6):350-4 [on line] PMID: 12441828 [найдено 30.07.2008]. *
Реферат базы данных PubMed: LEGROS В. et al. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med. 2003 Jan; 4(1):51-5 [on line] PMID: 14592360 [найдено 06.02.2009]. ZAKRZEWSKA J.M. et al. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J. Neurol. Neurosurg. Psychiatry. 1989 Apr; 52(4):472-6. *

Also Published As

Publication number Publication date
SG146631A1 (en) 2008-10-30
US20060270658A1 (en) 2006-11-30
CA2537060A1 (en) 2005-03-10
KR20060118426A (ko) 2006-11-23
WO2005020968A3 (en) 2005-05-19
BRPI0414112A (pt) 2006-10-31
MXPA06002392A (es) 2006-06-20
EP1663247B1 (en) 2009-10-28
IS8373A (is) 2006-03-24
JP2007513056A (ja) 2007-05-24
ATE446759T1 (de) 2009-11-15
AU2004268381B2 (en) 2009-06-18
TNSN06072A1 (en) 2007-10-03
DE602004023861D1 (de) 2009-12-10
WO2005020968A2 (en) 2005-03-10
MA28036A1 (fr) 2006-07-03
AU2004268381A1 (en) 2005-03-10
IL173822A0 (en) 2006-07-05
EP1663247A2 (en) 2006-06-07
RU2006110550A (ru) 2007-12-20
NO20061515L (no) 2006-06-06

Similar Documents

Publication Publication Date Title
JP2023171776A (ja) 成人における焦点てんかんの処置のための合成経皮的カンナビジオール
KR101370096B1 (ko) 타액 분비 과다증 치료를 위한 알파-2 수용체 작용제(클로니딘) 및 항-무스카린제(옥시부티닌)의 복합물
IL153233A (en) Extruded foam reinforcement
US6689399B1 (en) Transdermal delivery of an anti-inflammatory composition
WO2000037078A1 (de) Kombination von cerivastatin und fibraten
US20140051750A1 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
CA2735834C (en) Composition comprising ibuprofen and paracetamol to treat pain caused by osteoarthritis and rheumatoid arthritis
KR20070011276A (ko) 쿠에티아핀 항정신병제를 사용한 정신병의 치료
RU2369393C2 (ru) Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна
JPH01261334A (ja) アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法
ES2250749T3 (es) Uso de una composicion combinada que comprende propionil l-carnitina y otros farmacos para el tratamiento de la disfuncion erectil.
KR100906086B1 (ko) 활성 물질로서 도코사헥사엔산을 포함하는 지방이상증 치료를 위한 약제학적 조성물
US20050009813A1 (en) Use of desoxypeganine for treating clinical depression
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
RU2215527C2 (ru) Способ купирования алкогольного абстинентного синдрома, алкогольного делирия, острого алкогольного галлюциноза
EP4646204A1 (en) Compound for treatment of erectile dysfunction
ZA200601502B (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and improvement of sleep
RU2345763C1 (ru) Способ купирования и предупреждения побочных сердечно-сосудистых явлений при применении ингибиторов фосфодиэстеразы 5-го типа для лечения расстройств эрекции у мужчин
AU2015254669A1 (en) Nitisinone dosing regimens for the treatment of alkaptonuria
HK1053609B (en) Candesartan for treating migraine
HK1100840A (en) Compositions and methods to treat recurrent medical conditions

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090903